Botulinum toxin urethral sphincter injection resolves urinary retention after pubovaginal sling operation

Int Urogynecol J Pelvic Floor Dysfunct. 2002;13(1):55-6. doi: 10.1007/s001920200013.

Abstract

The management of prolonged urinary retention following pubovaginal sling surgery typically involves transvaginal urethrolysis for anatomical urethral obstruction. Brubaker recently reported on urethral sphincter abnormalities as a cause of postoperative urinary retention following either Burch suspension or a pubovaginal sling procedure. We report a case of functional urethral obstruction and detrusor acontractility following pubovaginal sling surgery that was successfully treated by botulinum A toxin urethral sphincter injection.

Publication types

  • Case Reports
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Aged
  • Botulinum Toxins, Type A / administration & dosage
  • Botulinum Toxins, Type A / therapeutic use*
  • Female
  • Humans
  • Injections
  • Neuromuscular Agents / administration & dosage
  • Neuromuscular Agents / therapeutic use*
  • Postoperative Complications*
  • Pubic Bone / surgery*
  • Urethra / drug effects*
  • Urinary Retention / drug therapy*
  • Urinary Retention / etiology*
  • Urologic Surgical Procedures / adverse effects*
  • Vagina / surgery*

Substances

  • Neuromuscular Agents
  • Botulinum Toxins, Type A